Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Braveiy Biotechnology (formerly Xuancheng Braveiy Bioengineering) is a leading Chinese contract development and manufacturing organization (CDMO) specializing in nutritional and dietary supplements. Founded in 2006 and headquartered in Xuancheng, Anhui Province, the company provides end-to-end OEM/ODM services, including product development, formulation, manufacturing, packaging, and logistics. Braveiy's extensive manufacturing capabilities cover a wide range of dosage forms, such as softgels, tablets, effervescent tablets, hard capsules, powders, and functional drinks. In December 2024, Braveiy was acquired by the European CDMO group Ourvita (backed by Investindustrial) to establish Ourvita Asia and expand its global footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Braveiy Bioengineering.